| 29.01.2025 11:47 | MTEC, PRES, GSK | UK earnings, trading statements calendar - next 7 days | Alliance |
| 28.01.2025 09:10 | GSK | GSK applications for sinus disease treatment accepted for review | Alliance |
| 28.01.2025 07:05 | GSK | Depemokimab dual filing in China and Japan | RNS |
| 28.01.2025 07:00 | GSK | EMA accepts two submissions for depemokimab | RNS |
| 27.01.2025 09:05 | GSK | GSK and University of Oxford researchers to create cancer vaccine | Alliance |
| 27.01.2025 08:49 | GSK | GSK shingles treatment application accepted for review in Europe | Alliance |
| 27.01.2025 07:05 | GSK | EMA accept review Shingrix syringe presentation | RNS |
| 20.01.2025 09:56 | ABDP, SFR, SYNT | LONDON BROKER RATINGS: Jefferies raises Spirax; Peel Hunt cuts Grainger | Alliance |
| 20.01.2025 08:40 | GSK | GSK gets EU nod for expanded use of Jemperli in endometrial cancer | Alliance |
| 20.01.2025 07:00 | GSK | Jemperli expanded approval in the EU | RNS |
| 16.01.2025 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 15.01.2025 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 15.01.2025 08:43 | GSK, HLN | UPDATE: Pfizer cuts stake in Haleon to 7% in GBP2.5 billion share sale | Alliance |
| 14.01.2025 17:24 | GSK, HLN | Pfizer to more than halve Haleon holding in GBP2.57 billion sale | Alliance |
| 14.01.2025 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 13.01.2025 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 13.01.2025 09:08 | GSK | GSK to buy precision therapeutics firm IDRx for up to USD1.15 billion | Alliance |
| 13.01.2025 07:00 | GSK | GSK enters agreement to acquire IDRx, Inc. | RNS |
| 10.01.2025 08:58 | GSK | GSK awaits FDA review of new shingles vaccine presentation | Alliance |
| 10.01.2025 07:00 | GSK | Shingrix fully liquid accepted for US FDA review | RNS |
| 07.01.2025 09:12 | GSK | GSK hails FDA breakthrough therapy designation for bone cancer drug | Alliance |
| 07.01.2025 07:00 | GSK | GSK ADC gets FDA breakthrough therapy designation | RNS |
| 03.01.2025 08:21 | GSK | GSK treatment approved for adults with sinus condition in China | Alliance |
| 03.01.2025 07:00 | GSK | GSK’s Nucala approved in China for use in CRSwNP | RNS |
| 02.01.2025 15:00 | GSK | Total Voting Rights | RNS |
| 02.01.2025 12:06 | XPS, WWH, WKP | UK dividends calendar - next 7 days | Alliance |
| 31.12.2024 10:50 | GSK, SAR | Sareum served notice on commercial licence for cancer treatment | Alliance |
| 23.12.2024 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 20.12.2024 09:00 | GSK | Block Listing Application | RNS |
| 20.12.2024 08:58 | GSK | GSK reports mixed findings from ovarian cancer phase III study | Alliance |
| 20.12.2024 07:00 | GSK | Headline results from phase III FIRST trial | RNS |
| 16.12.2024 09:34 | GSK | GSK receives three positive regulatory updates on cancer products | Alliance |
| 16.12.2024 07:11 | GSK | Jemperli receives US FDA breakthrough designation | RNS |
| 16.12.2024 07:05 | GSK | EMA grants PRIME Designation for GSK’227 | RNS |
| 16.12.2024 07:00 | GSK | Jemperli receives positive CHMP opinion | RNS |
| 10.12.2024 10:01 | AVCT, SFOR, SUPR | LONDON BROKER RATINGS: RBC raises Hikma; JPMorgan cuts Schroders | Alliance |
| 09.12.2024 19:42 | GSK | IN BRIEF: GSK highlights positive Blenrep data from Dreamm-7 trial | Alliance |
| 09.12.2024 08:47 | GSK | GSK's Nucala and Blenrep receive regulatory boost in US and China | Alliance |
| 05.12.2024 09:19 | GSK | GSK expands Chinese shingles vaccine collaboration with Zhifei | Alliance |
| 05.12.2024 07:00 | GSK | Zhifei China collaboration revised and extended | RNS |
| 04.12.2024 09:26 | WPP, HLN, GSK | Vodafone taps former GSK CFO Simon Dingemans as non-executive director | Alliance |
| 02.12.2024 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 02.12.2024 15:00 | GSK | Total Voting Rights | RNS |
| 02.12.2024 09:34 | ABF, BATS, GSK | LONDON BROKER RATINGS: Deutsche Bank raises AB Foods and Burberry | Alliance |
| 27.11.2024 09:23 | GSK | TOP NEWS: GSK hails EU Approval of Menveo vaccine in new format | Alliance |
| 27.11.2024 07:00 | GSK | GSK liquid meningitis vaccine authorised in EU | RNS |
| 25.11.2024 08:54 | GSK | GSK's Blenrep combinations accepted for review by US FDA | Alliance |
| 25.11.2024 07:00 | GSK | Blenrep combinations accepted for US FDA review | RNS |
| 22.11.2024 08:40 | GSK | TOP NEWS: GSK's Arexvy RSV vaccine approved in Japan for adults 50-59 | Alliance |
| 22.11.2024 07:00 | GSK | Japan approves first RSV vaccine for adults 50-59 | RNS |
| 19.11.2024 09:24 | GSK | GSK hails positive results for linerixibat in treating relentless itch | Alliance |
| 18.11.2024 09:36 | PAY, OMU, SBRE | LONDON BROKER RATINGS: HSBC says 'buy' recruiters SThree and Hays | Alliance |
| 14.11.2024 08:54 | GSK | GSK hails survival results in blood cancer patients with Blenrep | Alliance |
| 14.11.2024 07:00 | GSK | GSK announces overall survival results for Blenrep | RNS |
| 13.11.2024 15:00 | GSK | Block listing Interim Review | RNS |
| 12.11.2024 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 12.11.2024 09:35 | WHR, LABS, AIBG | LONDON BROKER RATINGS: Jefferies cuts Big Yellow, Shore cuts ITV | Alliance |
| 11.11.2024 15:01 | GSK | GSK publishes provisional 2025 dividend dates | RNS |
| 08.11.2024 09:39 | ASC, SFOR, SRC | LONDON BROKER RATINGS: Citigroup lifts Great Portland Estates to 'buy' | Alliance |
| 07.11.2024 16:24 | CCEP, AERI, HSD | UK dividends calendar - next 7 days | Alliance |
| 04.11.2024 16:16 | GOT, GSK, MTL | DIRECTOR DEALINGS: Drachs ups stake in Metals Exploration as CFO sells | Alliance |
| 01.11.2024 15:00 | GSK | Total Voting Rights | RNS |
| 01.11.2024 09:43 | LIO, SYNT, ASC | LONDON BROKER RATINGS: Deutsche cuts Smith & Nephew; Shore lifts Asos | Alliance |
| 31.10.2024 09:47 | EMG, CBG, BRBY | LONDON BROKER RATINGS: HSBC and Bernstein lift Burberry | Alliance |
| 30.10.2024 14:29 | GSK | Director/PDMR Shareholding | RNS |
| 30.10.2024 09:28 | GSK | TOP NEWS: GSK backs guidance despite third-quarter hit from Zantac | Alliance |
| 30.10.2024 07:00 | GSK | 3rd Quarter Results | RNS |
| 29.10.2024 12:48 | GSK | GSK inks deal to buy lupus therapy from Chimagen for USD300 million | Alliance |
| 24.10.2024 09:22 | GSK | IN BRIEF: GSK says Arexvy vaccine tests show wider potential for RSV | Alliance |
| 24.10.2024 07:00 | GSK | New positive Arexvy data in younger adults at risk | RNS |
| 23.10.2024 14:53 | STAN, SWR, NXT | UK earnings, trading statements calendar - next 7 days | Alliance |
| 17.10.2024 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 16.10.2024 16:09 | GSK | Director/PDMR Shareholding | RNS |
| 16.10.2024 08:33 | GSK | GSK's application for urinary tract infections drug is accepted | Alliance |
| 16.10.2024 07:00 | GSK | FDA accepts new drug application for gepotidacin | RNS |
